All sponsors

Avidity Biosciences, Inc.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-33
RECRUITING2
READOUTS ≤12 MONTHS1
Open Avidity Biosciences, Inc. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
EXPLORE44OLE
NCT06244082
P2Active, not recruitingDMD; Duchenne Muscular Dystrophy392027-04-30 (+16 mo)
FORTITUDE-3
NCT07038200
P3RecruitingFacioscapulohumeral Muscular Dystrophy; FSHD2002028-05
SAFARI44
NCT07587242
P3RecruitingMuscular Dystrophies; Muscular Dystrophies (Duchenne, Becker, Myotonic Dystrophy)702029-05
FORTITUDE-OLE
NCT06547216
P2Active, not recruitingFSHD; FSHD1842030-04 (+24 mo)
HARBOR-OLE
NCT07008469
P3Enrolling by invitationMyotonic Dystrophy Type 1; DM11992030-10 (+2 mo)